Personal information

Countries

China

Activities

Collapse all

Works (22)

Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate

Nature Communications
2024-10-04 | Journal article | Author
DOI: 10.1038/s41467-024-52908-z
Part of ISSN: 2041-1723
Contributors: Dan Fu; Wenming Wang; Yan Zhang; Fan Zhang; Pinyi Yang; Chun Yang; Yufei Tian; Renqi Yao; Jingwu Jian; Zixian Sun et al.
Source: Self-asserted source
Lei Zhao

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

npj Precision Oncology
2022-01-18 | Journal article
DOI: 10.1038/s41698-021-00243-7
Contributors: Fan Zhang; Jinliang Wang; Yu Xu; Shangli Cai; Tao Li; Guoqiang Wang; Chengcheng Li; Lei Zhao; Yi Hu
Source: check_circle
Crossref

Novel Cancer Immunotherapies and Antitumor Immunity

Journal of Immunology Research
2019-07-22 | Journal article
DOI: 10.1155/2019/3742061
Contributors: Lei Zhao; Jianjun Zhang; Liang Xu; Hussein A. Abbas
Source: check_circle
Crossref

Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy

Journal of Immunology Research
2019-02-11 | Journal article
DOI: 10.1155/2019/4516041
Contributors: Shixue Chen; Lingling Li; Fan Zhang; Yu Wang; Yi Hu; Lei Zhao
Source: check_circle
Crossref

Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20–243 CrossMab

mAbs
2014-03-03 | Journal article
DOI:

10.4161/mabs.28613
Contributors: Lei Zhao; Feiyue Xie; Xin Tong; Huafei Li; Yaling Chen; Weizhu Qian; Shuyan Duan; Juan Zheng; Ziye Zhao; Bohua Li et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization.

2013-11 | Journal article
DOI:

10.1158/0008-5472.CAN-13-0657

PMID:

24046294
Contributors: Li B; Meng Y; Zheng L; Zhang X; Tong Q; Tan W; Hu S; Li H; Chen Y; Song J et al.
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFP

Blood
2013-10 | Journal article
DOI:

10.1182/blood-2013-04-496554
Contributors: L. Zhao; Q. Tong; W. Qian; B. Li; D. Zhang; T. Fu; S. Duan; X. Zhang; J. Zhao; J. Dai et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox

Molecular Immunology
2011-09 | Journal article
DOI:

10.1016/j.molimm.2011.06.435
Contributors: Haiou Yang; Huaizu Guo; Kexing Fan; Bo Zhang; Lei Zhao; Sheng Hou; Weizhu Qian; Dapeng Zhang; Hao Wang; Jianxing Dai et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Identification of a novel functional domain of ricin responsible for its potent toxicity.

2011-04 | Journal article
DOI:

10.1074/jbc.M110.196584

PMID:

21303906

PMC:

PMC3069421
Contributors: Dai J; Zhao L; Yang H; Guo H; Fan K; Wang H; Qian W; Zhang D; Li B; Wang H et al.
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin

Cancer Letters
2010 | Journal article
DOI:

10.1016/j.canlet.2010.08.011
Contributors: Geng Kou; Jingping Shi; Lin Chen; Dapeng Zhang; Sheng Hou; Lei Zhao; Chen Fang; Lei Zheng; Xunming Zhang; Ping Liang et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Construction and characterization of a bispecific anti-CD20 antibody with potent antitumor activity against B-cell lymphoma.

2010-08 | Journal article
DOI:

10.1158/0008-5472.CAN-10-0009

PMID:

20631068
Contributors: Li B; Zhang X; Shi S; Zhao L; Zhang D; Qian W; Zheng L; Gao J; Wang H; Guo Y
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma

Cancer Letters
2010-06 | Journal article
DOI:

10.1016/j.canlet.2009.12.004
Contributors: Lan Wu; Chong Wang; Dapeng Zhang; Xunming Zhang; Weizhu Qian; Lei Zhao; Hao Wang; Bohua Li; Yajun Guo
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.

2010-03 | Journal article
DOI:

10.1158/0008-5472.CAN-09-3488

PMID:

20197464
Contributors: Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H et al.
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

The protein-protein interface evolution acts in a similar way to antibody affinity maturation.

2010-02 | Journal article
DOI:

10.1074/jbc.M109.076547

PMID:

20007707

PMC:

PMC2823529
Contributors: Li B; Zhao L; Wang C; Guo H; Wu L; Zhang X; Qian W; Wang H; Guo Y
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo

Cancer Immunol Immunother
2010-01-07 | Journal article
DOI:

10.1007/s00262-009-0812-6
Contributors: Jianxin Dai; Bohua Li; Jinping Shi; Ling Peng; Dapeng Zhang; Weizhu Qian; Sheng Hou; Lei Zhao; Jie Gao; Zhiguo Cao et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma

Blood
2009-10 | Journal article
DOI:

10.1182/blood-2009-06-225474
Contributors: B. Li; L. Zhao; H. Guo; C. Wang; X. Zhang; L. Wu; L. Chen; Q. Tong; W. Qian; H. Wang et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Development and characterization of a fully functional small anti-HER2 antibody.

2009-10 | Journal article
PMID:

19874707
Contributors: Gao J; Li B; Li H; Zhang X; Zhang D; Zhao L; Wang C; Fang C; Qian W; Hou S et al.
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo

Cancer Immunol Immunother
2009-08 | Journal article
DOI:

10.1007/s00262-009-0754-z
Contributors: Jianxin Dai; Bohua Li; Jinping Shi; Ling Peng; Dapeng Zhang; Weizhu Qian; Sheng Hou; Lei Zhao; Jie Gao; Zhiguo Cao et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab

Biochemical and Biophysical Research Communications
2008-10 | Journal article
DOI:

10.1016/j.bbrc.2008.08.055
Contributors: Lei Zheng; Bohua Li; Weizhu Qian; Lei Zhao; Zhiguo Cao; Shu Shi; Jie Gao; Dapeng Zhang; Sheng Hou; Jianxin Dai et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.

2008-04 | Journal article
DOI:

10.1158/0008-5472.CAN-07-6663

PMID:

18381448
Contributors: Li B; Shi S; Qian W; Zhao L; Zhang D; Hou S; Zheng L; Dai J; Zhao J; Wang H et al.
Source: Self-asserted source
Lei Zhao via Europe PubMed Central

Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody

Biochemical and Biophysical Research Communications
2007-06 | Journal article
DOI:

10.1016/j.bbrc.2007.04.039
Contributors: Bohua Li; Hao Wang; Dapeng Zhang; Weizhu Qian; Sheng Hou; Shu Shi; Lei Zhao; Geng Kou; Zhiguo Cao; Jianxin Dai et al.
Source: Self-asserted source
Lei Zhao via Crossref Metadata Search

METHOD OF ACQUIRING PROTEINS WITH HIGH AFFINITY BY COMPUTER AIDED DESIGN

Patent
OTHER-ID:

WO2011035456
Contributors: GUO YAJUN; LI BOHUA; WANG HAO; HOU SHENG; ZHAO LEI
Source: Self-asserted source
Lei Zhao via Europe PubMed Central
How many people are using ORCID?